MirImmune is Drug Discovery in United States that focus on cell-based immunotherapies business. Founded in 2014. They cover business area such as developer, immunotherapy treatment, cancer, development, long-term survival, two main approach, immune checkpoint inhibition, cell-base immunotherapy.
2014
( 10 years old in 2024 )
Cell-based Immunotherapies
-
Cambridge Biolabs, One Kendall Square
Building 200, Suite 2203
Cambridge, MA 02139
United States
Private
developerimmunotherapy treatmentcancerdevelopmentlong-term survivaltwo main approachimmune checkpoint inhibitioncell-base immunotherapy
* We use standard office opening hours in near MirImmune's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MirImmune is Drug Discovery business from United States that founded in 2014 (10 years old in 2024), MirImmune business is focusing on Cell-based Immunotherapies.
MirImmune headquarter office and corporate office address is located in Cambridge Biolabs, One Kendall Square Building 200, Suite 2203 Cambridge, MA 02139 United States.
MirImmune was founded in United States.
In 2024, MirImmune is currently focus on cell-based immunotherapies sector.
Above is snippet of Google Trends for "cell-based immunotherapies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MirImmune, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
